Thank you for submitting your question. You will get a reply within two business days to the email you provided. Thank you.
Active, Not Recruiting
An Investigational Immuno-therapy Study of Nivolumab, and Nivolumab in Combination With Other Anti-cancer Drugs, in Colon Cancer That Has Come Back or Has Spread - CA209-142
Updated: 03 December, 2018 | ClinicalTrials.gov
This clinical trial is now complete.
For clinical trial results please visit ClinicalTrials.gov.